FDA says knockoff versions of Lilly obesity drug must come off the market
Dec 19, 2024
Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and diabetes will need to phase out their versions next year under a federal decision issued Thursday.
https://www.washingtontimes.com/news/2024/dec/19/fda-says-offbrand-versions-zepbound-mounjaro-must-/?utm_source=RSS_Feed&utm_medium=RSS
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service